Literature DB >> 19602424

Effects of cannabinoid drugs on the reinforcing properties of food in gestationally undernourished rats.

Alexa A Wakley1, Erin B Rasmussen.   

Abstract

Involvement of the endocannabinoids in hyperphagia has been demonstrated, however, behavioral characterization of its role in food reinforcement is limited. The present study investigated whether 2-arachidonoyl glycerol, an endocannabinoid ligand, and rimonabant, a CB1 antagonist, change the reinforcing properties of food in gestationally undernourished rats (a putative model of obesity) vs controls. Albino dams were food deprived by 0 to 45% of their free-feeding weights up to day 18 of their gestational period. Their offspring were allowed to free-feed until postnatal day 75. Then, behavior of the offspring was placed under progressive ratio schedules of sucrose reinforcement. After baseline data were established, intraperitoneal injections of 2-AG (0.03-3.75 mg/kg), and rimonabant (SR141716, 0.3-3.0 mg/kg) were administered and compared across group. Results show gestationally undernourished (GU) rats as adults weighed less than controls at the time of testing and female offspring allowed to free-feed for over 35 weeks exhibited lower body weights than controls. Under baseline, GU rats had lower breakpoints than controls. 2-AG and rimonabant significantly increased and decreased, respectively, breakpoint and responses made per session, suggesting involvement of the cannabinoid system in food reinforcement. When comparing peak doses of 2-AG on breakpoint, gestationally undernourished rats exhibited lower peak doses than controls. These data suggest that under the gestation deprivation method employed, GU rats were thinner and had lower food reinforcer efficacy than controls, and may have heightened sensitivity to 2-AG.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19602424     DOI: 10.1016/j.pbb.2009.07.002

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  8 in total

1.  Noladin ether, a putative endocannabinoid, enhances motivation to eat after acute systemic administration in rats.

Authors:  E K Jones; T C Kirkham
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

2.  Rimonabant abolishes sensitivity to workload changes in a progressive ratio procedure.

Authors:  Julie A Marusich; Jenny L Wiley
Journal:  Pharmacol Biochem Behav       Date:  2012-03-09       Impact factor: 3.533

3.  Cannabinoids and value-based decision making: implications for neurodegenerative disorders.

Authors:  Angela M Lee; Erik B Oleson; Leontien Diergaarde; Joseph F Cheer; Tommy Pattij
Journal:  Basal Ganglia       Date:  2012-07-28

Review 4.  The utility of behavioral economics in expanding the free-feed model of obesity.

Authors:  Erin B Rasmussen; Stephen H Robertson; Luis R Rodriguez
Journal:  Behav Processes       Date:  2016-02-23       Impact factor: 1.777

5.  Paradoxical effects of the endocannabinoid uptake inhibitor VDM11 on accumbal neural encoding of reward predictive cues.

Authors:  Erik B Oleson; Joseph F Cheer
Journal:  Synapse       Date:  2012-07-27       Impact factor: 2.562

6.  Anticonvulsive effects of endocannabinoids; an investigation to determine the role of regulatory components of endocannabinoid metabolism in the Pentylenetetrazol induced tonic- clonic seizures.

Authors:  Parisa Zareie; Mehdi Sadegh; Mohammad Reza Palizvan; Homeira Moradi-Chameh
Journal:  Metab Brain Dis       Date:  2018-03-04       Impact factor: 3.584

7.  Cocaine-induced increases in motivation require 2-arachidonoylglycerol mobilization and CB1 receptor activation in the ventral tegmental area.

Authors:  Sheila A Engi; Erin J Beebe; Victoria M Ayvazian; Fabio C Cruz; Joseph F Cheer; Jennifer M Wenzel; Natalie E Zlebnik
Journal:  Neuropharmacology       Date:  2021-05-28       Impact factor: 5.273

8.  Quantitative analysis of performance on a progressive-ratio schedule: effects of reinforcer type, food deprivation and acute treatment with Δ⁹-tetrahydrocannabinol (THC).

Authors:  C M Olarte-Sánchez; L Valencia-Torres; H J Cassaday; C M Bradshaw; E Szabadi
Journal:  Behav Processes       Date:  2015-01-28       Impact factor: 1.777

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.